Molecular Insight Pharmaceuticals' Grant

Molecular Insight Pharmaceuticals raised a round of funding on July 02, 2009. Investors include National Cancer Institute.

Molecular Insight is a clinical-stage biopharmaceutical company focused on the critical unmet diagnostic and therapeutic needs of the prostate cancer patient. The Company is targeting the development …

Articles about Molecular Insight Pharmaceuticals' Grant: